vancomycin in terms of the volume of distribution and the rate of drug clearance from plasma.1. The risk of ototoxicity and nephrotoxicity from vancomycin
2024 Jan; 92(1): . Page 28. Vancomycin Ototoxicity. Vancomycin is a glycopeptide antibiotic used for. MRSA, strep endocarditis, and Clostridium
vancomycin (Vancocin) Similar to aminoglycosides in that it may be ototoxic when used intravenously in life-threatening infections. The fact that
vancomycin (Vancocin) Similar to aminoglycosides in that it may be ototoxic when used intravenously in life-threatening infections. The fact that
Ototoxicity may be more common in patients with renal impairment. Pre-existing hearing loss may increase risk of ototoxicity from vancomycin.(2, 3).
This is known as ototoxicity and can lead to permanent sensorineural hearing loss, dizziness and tinnitus. vancomycin (Vancocin). Note that
Long-term vancomycin use had low risk of ototoxicity List of references Publications that cite this publication.
Moderate ototoxicity (40 decibels) in this case improved after 15 days following vancomycin administration.8 Thus, vancomycin-associated
by DP Levine 2024 Cited by 1158Vancomycin ototoxicity in patient with normal renal function. Ann Brummett RE. Ototoxicity of vancomycin and analogues. Otolaryngol. Clin North
Comments